Capstone Investment Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-4,800
Closed -$346K – 1848
2024
Q4
$346K Buy
4,800
+1,900
+66% +$140K ﹤0.01% 1440
2024
Q3
$232K Buy
+2,900
New +$218K ﹤0.01% 1524
2024
Q2
– Sell
-500
Closed -$35.2K – 2466
2024
Q1
$35.2K Buy
+500
New +$35.8K ﹤0.01% 2234
2023
Q4
– Sell
-3,200
Closed -$218K – 2400
2023
Q3
$218K Buy
3,200
+900
+39% +$71.1K ﹤0.01% 1771
2023
Q2
$188K Buy
+2,300
New +$185K ﹤0.01% 1576
2022
Q2
– Sell
-400
Closed -$43K – 2110
2022
Q1
$43K Buy
+400
New +$41.3K ﹤0.01% 1892
2021
Q4
– Sell
-2,000
Closed -$242K – 2085
2021
Q3
$242K Buy
+2,000
New +$243K ﹤0.01% 1669

Other funds holding TECH

Capstone Investment Advisors's TECH Position: Q2 2026 in Review

Capstone Investment Advisors opened a new position in Bio-Techne (TECH) in Q2 2026: 210,000 shares worth $14.8M. The stake represents 0.03% of the portfolio and ranks #262 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in TECH as recently as Q3 2025.

Capstone Investment Advisors first reported a position in TECH in Q4 2016 and has held it in 10 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Capstone Investment Advisors held 210,000 shares of Bio-Techne worth $14.8M as of Q2 2026.
  • Bio-Techne was a new Capstone Investment Advisors position in Q2 2026.
  • Bio-Techne made up 0.03% of Capstone Investment Advisors's portfolio in Q2 2026, its #262 holding.
  • Capstone Investment Advisors first reported a position in Bio-Techne in Q4 2016 and has held it in 10 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.